Pancreatic cancer is one of the most common causes of cancer-related deaths in New South Wales and Australia. Over the last several decades, through the combined and dedicated effort of the pancreatic cancer team of surgeons, clinicians, nurses and researchers, the Royal North Shore Hospital campus has evolved to become a high-volume centre of excellence in pancreatic cancer surgery, treatment and research. Our patients have experienced some of the best outcomes achieved in Australia, living twice as long after diagnosis compared to the average Australian pancreatic cancer patient.
In this very special Christmas Kolling Knowledge event, Associate Professor Pavlakis along with Associate Professor Viive Howell from the Bill Walsh Translational Cancer Research Laboratory, Kolling Institute, will talk about the innovative research conducted here at the Institute and how this has led to being able to use biomarkers in tumour tissue to predict patient outcomes.
Sandy Eglin who has been treated by A/Prof Pavlakis will share her story and highlight why she is forever grateful for the wonderful support and dedication of our oncologists and researchers.
Join us at 10 am for the event opening, informative session & a morning tea.
Associate Professor of Medicine - University of Sydney Northern Clinical School & Co-Head, Bill Walsh Translational Cancer Research Laboratory, Kolling Institute, RNSH/NSLHD
Associate Professor, The University of Sydney Northern Clinical School, Faculty of Medicine and Health & Laboratory Research Director, Bill Walsh Translational Cancer Research Laboratory
CLICK HERE to register your attendance. Alternatively, call us on 02 9436 0610.
Can’t attend? Please CLICK HERE to support our oncologists and researchers at the Kolling Institute of Medical Research.